48,830
edits
(→IHC) |
|||
Line 87: | Line 87: | ||
*AMACR +ve. | *AMACR +ve. | ||
*CK7 -ve/+ve (focally in 2/3 tumours<ref name=pmid23157747>{{Cite journal | last1 = Zhang | first1 = SH. | last2 = Shi | first2 = SF. | last3 = Huang | first3 = SF. | last4 = Zhang | first4 = YN. | last5 = Zheng | first5 = YY. | last6 = Chen | first6 = GY. | title = [Clinical and pathologic features of tubulocystic carcinoma of kidney]. | journal = Zhonghua Bing Li Xue Za Zhi | volume = 41 | issue = 8 | pages = 543-6 | month = Aug | year = 2012 | doi = | PMID = 23157747 }}</ref>). | *CK7 -ve/+ve (focally in 2/3 tumours<ref name=pmid23157747>{{Cite journal | last1 = Zhang | first1 = SH. | last2 = Shi | first2 = SF. | last3 = Huang | first3 = SF. | last4 = Zhang | first4 = YN. | last5 = Zheng | first5 = YY. | last6 = Chen | first6 = GY. | title = [Clinical and pathologic features of tubulocystic carcinoma of kidney]. | journal = Zhonghua Bing Li Xue Za Zhi | volume = 41 | issue = 8 | pages = 543-6 | month = Aug | year = 2012 | doi = | PMID = 23157747 }}</ref>). | ||
Notes: | |||
*IHC profile essentially that of [[PaRCC]].{{fact}} | |||
==See also== | ==See also== |
edits